At Cancer Council, we’re here every minute, every hour, every day for Australians affected by cancer.
Cancer Council is proud of our footprint in cancer research. Every day, our researchers are focussed on finding ways to reduce the impact of cancer.
Research experts, cancer patients, survivors and carers help us decide what research to fund. We assess both the scientific merit of a project and its potential impact on the community.
In 2017/18 Cancer Council NSW provided funding to support 70 world-class cancer research projects, with 256 researchers across 16 institutions.
Professor David Watkins and his team have discovered a naturally occurring hormone that could be used to reverse resistance in lung cancer treatment and improve the effectiveness of chemotherapy.
Prof David Gottlieb's research has discovered that the treatment of using enhanced white blood cells to fight infection and leukemia can reduce side effects in bone marrow transplant recipients.
Prof David Gottlieb's research arose out of a desire to overcome poor outcomes in clinical practice. He wants to develop better treatments that can have direct and clear benefits for patients.
A team of researchers led by Dr Nicole Verrills has been investigating if a new ‘gene marker’ can predict which breast cancer patients may have poorer treatment outcomes.
Shirley Baxter talks about representing consumers in deciding what research Cancer Council funds.
Researchers at Cancer Council NSW have conducted an Australian-first study that estimated future bowel cancer rates and deaths.
Dr Lionel Hebbard and his team conducted a long-range study that aimed to quantify the exact impact of metabolic drivers, particularly obesity, on liver cancer prognosis and progression in patients.
Researchers at Cancer Council NSW found that compared to the general population, men who survived melanoma have a higher risk of being diagnosed with prostate cancer later in life.
Dr Nair-Shalliker's research is focussed on identifying environmental, lifestyle and molecular risk factors of prostate cancer, including sun exposure, using various population-based datasets.
Professor Xu Dong Zhang and his team investigated the role a particular protein plays in melanoma cell survival.
A team of Cancer Council researchers has shown that physical activity is an important factor in preventing cancer, particularly cancer of the colon, irrespective of body weight.
Our researchers are providing crucial evidence to support prevention strategies both in Australia and around the world.
Kirsty Browne talks about her experience with cancer and becoming a peer support volunteer.
Lyndal Wellard-Cole and her team set out to determine what impact, if any, the legislation has had on the kilojoule content of Australian fast foods.
Professor Robert Baxter and his team have tested a promising new therapy, which can effectively block the growth of triple negative breast cancer by inhibiting two proteins that act as stimulators.
Professor John Mattick and his team are using cutting-edge sequencing technologies to uncover various components of DNA and how they differ in cancer cells.
Tony Maxwell talks about his involvement in cancer support groups and representing consumers in deciding what research Cancer Council funds.
This project has worked to improve treatments and reduce the major challenge of some breast cancer patients’ resistance to endocrine therapy and relapse.
A study by Cancer Council NSW has found that rates of vulvar cancer have been increasing significantly from the late 1980s to the mid-2000s.
This research has provided a groundbreaking insight into the relationship between the protein dyskerin and neuroblastoma, a deadly childhood cancer.
A study by Cancer Council NSW has revealed that over 1 in 3 lung cancer patients seek emergency care around the time of diagnosis, highlighting the need for more research into early detection.